APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antidiuretic Hormone (ADH) Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antidiuretic Hormone (ADH) Drug Market Outlook and Growth Opportunities 2026

31 December 2025193 pages

Choose your research edition.

Industry ResearchAntidiuretic Hormone (ADH) Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiuretic Hormone (ADH) Drug Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Antidiuretic Hormone (ADH) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiuretic Hormone (ADH) Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiuretic Hormone (ADH) Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Antidiuretic Hormone (ADH) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antidiuretic Hormone (ADH) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antidiuretic Hormone (ADH) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiuretic Hormone (ADH) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antidiuretic Hormone (ADH) Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antidiuretic Hormone (ADH) Drug market include Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, Fresenius Kabi, Ferring Pharmaceuticals, Endo International and Cumberland Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Antidiuretic Hormone (ADH) Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antidiuretic Hormone (ADH) Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antidiuretic Hormone (ADH) Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antidiuretic Hormone (ADH) Drug market.

Antidiuretic Hormone (ADH) Drug Segment by Company

Hybio Pharmaceutical

Hainan Zhonghe Pharmaceutical

Fresenius Kabi

Ferring Pharmaceuticals

Endo International

Cumberland Pharmaceuticals

Antidiuretic Hormone (ADH) Drug Segment by Type

Premixed Solution

Injection

Antidiuretic Hormone (ADH) Drug Segment by Application

Diabetes Insipidus

Vasodilatory Shock

Others

Antidiuretic Hormone (ADH) Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Antidiuretic Hormone (ADH) Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antidiuretic Hormone (ADH) Drug key companies, revenue, market share, and recent developments.

3. To split the Antidiuretic Hormone (ADH) Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antidiuretic Hormone (ADH) Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antidiuretic Hormone (ADH) Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Antidiuretic Hormone (ADH) Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiuretic Hormone (ADH) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiuretic Hormone (ADH) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiuretic Hormone (ADH) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antidiuretic Hormone (ADH) Drug industry.

Chapter 3: Detailed analysis of Antidiuretic Hormone (ADH) Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antidiuretic Hormone (ADH) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antidiuretic Hormone (ADH) Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antidiuretic Hormone (ADH) Drug Industry Trends Table 2. Antidiuretic Hormone (ADH) Drug Industry Drivers Table 3. Antidiuretic Hormone (ADH) Drug Industry Opportunities and Challenges Table 4. Antidiuretic Hormone (ADH) Drug Industry Restraints Table 5. Global Antidiuretic Hormone (ADH) Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antidiuretic Hormone (ADH) Drug Revenue Share by Company (2021-2026) Table 7. Global Antidiuretic Hormone (ADH) Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antidiuretic Hormone (ADH) Drug Key Company Manufacturing Base & Headquarters Table 9. Global Antidiuretic Hormone (ADH) Drug Company, Product Type & Application Table 10. Global Antidiuretic Hormone (ADH) Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antidiuretic Hormone (ADH) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Premixed Solution Table 15. Significant Companies of Injection Table 16. Global Antidiuretic Hormone (ADH) Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Antidiuretic Hormone (ADH) Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Antidiuretic Hormone (ADH) Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Type (2021-2026) Table 20. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diabetes Insipidus Table 22. Significant Companies of Vasodilatory Shock Table 23. Significant Companies of Others Table 24. Global Antidiuretic Hormone (ADH) Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Antidiuretic Hormone (ADH) Drug Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Antidiuretic Hormone (ADH) Drug Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Application (2021-2026) Table 28. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Application (2027-2032) Table 29. Global Antidiuretic Hormone (ADH) Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Antidiuretic Hormone (ADH) Drug Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Region (2021-2026) Table 32. Global Antidiuretic Hormone (ADH) Drug Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Region (2027-2032) Table 34. Global Antidiuretic Hormone (ADH) Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Antidiuretic Hormone (ADH) Drug Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Antidiuretic Hormone (ADH) Drug Sales Value Market Share by Country (2021-2026) Table 37. Global Antidiuretic Hormone (ADH) Drug Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Antidiuretic Hormone (ADH) Drug Sales Value Market Share by Country (2027-2032) Table 39. Hybio Pharmaceutical Company Information Table 40. Hybio Pharmaceutical Business Overview Table 41. Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio Table 43. Hybio Pharmaceutical Recent Development Table 44. Hainan Zhonghe Pharmaceutical Company Information Table 45. Hainan Zhonghe Pharmaceutical Business Overview Table 46. Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio Table 48. Hainan Zhonghe Pharmaceutical Recent Development Table 49. Fresenius Kabi Company Information Table 50. Fresenius Kabi Business Overview Table 51. Fresenius Kabi Antidiuretic Hormone (ADH) Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Fresenius Kabi Antidiuretic Hormone (ADH) Drug Product Portfolio Table 53. Fresenius Kabi Recent Development Table 54. Ferring Pharmaceuticals Company Information Table 55. Ferring Pharmaceuticals Business Overview Table 56. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio Table 58. Ferring Pharmaceuticals Recent Development Table 59. Endo International Company Information Table 60. Endo International Business Overview Table 61. Endo International Antidiuretic Hormone (ADH) Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Endo International Antidiuretic Hormone (ADH) Drug Product Portfolio Table 63. Endo International Recent Development Table 64. Cumberland Pharmaceuticals Company Information Table 65. Cumberland Pharmaceuticals Business Overview Table 66. Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio Table 68. Cumberland Pharmaceuticals Recent Development Table 69. Research Programs/Design for This Report Table 70. Authors List of This Report Table 71. Secondary Sources Table 72. Primary Sources List of Figures Figure 1. Antidiuretic Hormone (ADH) Drug Product Image Figure 2. Global Antidiuretic Hormone (ADH) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiuretic Hormone (ADH) Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiuretic Hormone (ADH) Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Premixed Solution Image Figure 8. Injection Image Figure 9. Global Antidiuretic Hormone (ADH) Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Antidiuretic Hormone (ADH) Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Type (2021-2032) Figure 12. Diabetes Insipidus Image Figure 13. Vasodilatory Shock Image Figure 14. Others Image Figure 15. Global Antidiuretic Hormone (ADH) Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antidiuretic Hormone (ADH) Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Application (2021-2032) Figure 18. Global Antidiuretic Hormone (ADH) Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032) & (US$ Million) Figure 21. North America Antidiuretic Hormone (ADH) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Antidiuretic Hormone (ADH) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Antidiuretic Hormone (ADH) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032) & (US$ Million) Figure 27. South America Antidiuretic Hormone (ADH) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Antidiuretic Hormone (ADH) Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Premixed Solution
  • Injection
Applications
  • Diabetes Insipidus
  • Vasodilatory Shock
  • Others
Companies covered
  • Hybio Pharmaceutical
  • Hainan Zhonghe Pharmaceutical
  • Fresenius Kabi
  • Ferring Pharmaceuticals
  • Endo International
  • Cumberland Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antidiuretic Hormone (ADH) Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antidiuretic Hormone (ADH) Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antidiuretic Hormone (ADH) Drug Market Dynamics
  1. 2.1 Antidiuretic Hormone (ADH) Drug Industry Trends
  2. 2.2 Antidiuretic Hormone (ADH) Drug Industry Drivers
  3. 2.3 Antidiuretic Hormone (ADH) Drug Industry Opportunities and Challenges
  4. 2.4 Antidiuretic Hormone (ADH) Drug Industry Restraints
3 Antidiuretic Hormone (ADH) Drug Market by Company
  1. 3.1 Global Antidiuretic Hormone (ADH) Drug Company Revenue Ranking in 2025
  2. 3.2 Global Antidiuretic Hormone (ADH) Drug Revenue by Company (2021-2026)
  3. 3.3 Global Antidiuretic Hormone (ADH) Drug Company Ranking (2024-2026)
  4. 3.4 Global Antidiuretic Hormone (ADH) Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Antidiuretic Hormone (ADH) Drug Company Product Type and Application
  6. 3.6 Global Antidiuretic Hormone (ADH) Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antidiuretic Hormone (ADH) Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antidiuretic Hormone (ADH) Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antidiuretic Hormone (ADH) Drug Market by Type
  1. 4.1 Antidiuretic Hormone (ADH) Drug Type Introduction
  2. 4.1.1 Premixed Solution
  3. 4.1.2 Injection
  4. 4.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Type
  5. 4.2.1 Global Antidiuretic Hormone (ADH) Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Type (2021-2032)
5 Antidiuretic Hormone (ADH) Drug Market by Application
  1. 5.1 Antidiuretic Hormone (ADH) Drug Application Introduction
  2. 5.1.1 Diabetes Insipidus
  3. 5.1.2 Vasodilatory Shock
  4. 5.1.3 Others
  5. 5.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Application
  6. 5.2.1 Global Antidiuretic Hormone (ADH) Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Antidiuretic Hormone (ADH) Drug Sales Value Share by Application (2021-2032)
6 Antidiuretic Hormone (ADH) Drug Regional Value Analysis
  1. 6.1 Global Antidiuretic Hormone (ADH) Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antidiuretic Hormone (ADH) Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032)
  7. 6.3.2 North America Antidiuretic Hormone (ADH) Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Antidiuretic Hormone (ADH) Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antidiuretic Hormone (ADH) Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032)
  16. 6.6.2 South America Antidiuretic Hormone (ADH) Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antidiuretic Hormone (ADH) Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antidiuretic Hormone (ADH) Drug Sales Value Share by Country, 2025 VS 2032
7 Antidiuretic Hormone (ADH) Drug Country-level Value Analysis
  1. 7.1 Global Antidiuretic Hormone (ADH) Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antidiuretic Hormone (ADH) Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antidiuretic Hormone (ADH) Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antidiuretic Hormone (ADH) Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antidiuretic Hormone (ADH) Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antidiuretic Hormone (ADH) Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hybio Pharmaceutical
  2. 8.1.1 Hybio Pharmaceutical Company Information
  3. 8.1.2 Hybio Pharmaceutical Business Overview
  4. 8.1.3 Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Hybio Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio
  6. 8.1.5 Hybio Pharmaceutical Recent Developments
  7. 8.2 Hainan Zhonghe Pharmaceutical
  8. 8.2.1 Hainan Zhonghe Pharmaceutical Company Information
  9. 8.2.2 Hainan Zhonghe Pharmaceutical Business Overview
  10. 8.2.3 Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hainan Zhonghe Pharmaceutical Antidiuretic Hormone (ADH) Drug Product Portfolio
  12. 8.2.5 Hainan Zhonghe Pharmaceutical Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Antidiuretic Hormone (ADH) Drug Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Ferring Pharmaceuticals
  20. 8.4.1 Ferring Pharmaceuticals Company Information
  21. 8.4.2 Ferring Pharmaceuticals Business Overview
  22. 8.4.3 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio
  24. 8.4.5 Ferring Pharmaceuticals Recent Developments
  25. 8.5 Endo International
  26. 8.5.1 Endo International Company Information
  27. 8.5.2 Endo International Business Overview
  28. 8.5.3 Endo International Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Endo International Antidiuretic Hormone (ADH) Drug Product Portfolio
  30. 8.5.5 Endo International Recent Developments
  31. 8.6 Cumberland Pharmaceuticals
  32. 8.6.1 Cumberland Pharmaceuticals Company Information
  33. 8.6.2 Cumberland Pharmaceuticals Business Overview
  34. 8.6.3 Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cumberland Pharmaceuticals Antidiuretic Hormone (ADH) Drug Product Portfolio
  36. 8.6.5 Cumberland Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst